sulfasalazine has been researched along with Multiple Primary Neoplasms in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lynch, PM | 1 |
Morris, JS | 1 |
Wen, S | 1 |
Advani, SM | 1 |
Ross, W | 1 |
Chang, GJ | 1 |
Rodriguez-Bigas, M | 1 |
Raju, GS | 1 |
Ricciardiello, L | 1 |
Iwama, T | 1 |
Rossi, BM | 1 |
Pellise, M | 1 |
Stoffel, E | 1 |
Wise, PE | 1 |
Bertario, L | 1 |
Saunders, B | 1 |
Burt, R | 1 |
Belluzzi, A | 1 |
Ahnen, D | 1 |
Matsubara, N | 1 |
Bülow, S | 1 |
Jespersen, N | 1 |
Clark, SK | 1 |
Erdman, SH | 1 |
Markowitz, AJ | 1 |
Bernstein, I | 1 |
De Haas, N | 1 |
Syngal, S | 1 |
Moeslein, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Sirolimus for Cowden Syndrome With Colon Polyposis[NCT04094675] | Phase 2 | 10 participants (Anticipated) | Interventional | 2019-09-16 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for sulfasalazine and Multiple Primary Neoplasms
Article | Year |
---|---|
A proposed staging system and stage-specific interventions for familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Colectomy; Colonoscopy; Colorectal Surgery; Consensus; Endoscopic Mucosa | 2016 |